Tan Li Selected Research

pseudolaric acid B

6/2018	Pseudolaric acid B attenuates atherosclerosis progression and inflammation by suppressing PPARγ-mediated NF-κB activation.
11/2017	Pseudolaric acid B attenuates atopic dermatitis-like skin lesions by inhibiting interleukin-17-induced inflammation.
4/2012	Topical application of Pseudolaric acid B improve DNFB-induced contact hypersensitivity via regulating the balance of Th1/Th17/Treg cell subsets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tan Li Research Topics

Disease

25	Neoplasms (Cancer) 04/2024 - 09/2005
9	Abdominal Aortic Aneurysm 04/2024 - 01/2021
6	Stroke (Strokes) 01/2023 - 01/2017
6	Inflammation (Inflammations) 06/2022 - 01/2017
5	Cognitive Dysfunction 01/2023 - 12/2018
5	Hypertension (High Blood Pressure) 01/2022 - 10/2005
4	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 12/2017
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 07/2014
4	Leukemia 12/2017 - 08/2008
3	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2022
3	Cerebral Infarction 01/2023 - 01/2017
3	Atherosclerosis 05/2020 - 06/2018
3	Papillomavirus Infections 01/2019 - 10/2018
3	Pain (Aches) 12/2018 - 10/2008
3	Skin Diseases (Skin Disease) 11/2017 - 04/2012
3	Contact Dermatitis (Eczema, Contact) 01/2013 - 01/2012
2	Lung Neoplasms (Lung Cancer) 04/2024 - 01/2019
2	Fibrosis (Cirrhosis) 02/2024 - 02/2016
2	Liver Diseases (Liver Disease) 01/2024 - 01/2015
2	COVID-19 12/2023 - 03/2023
2	Hypersensitivity (Allergy) 09/2023 - 12/2014
2	Infections 09/2023 - 03/2009
2	Acute-On-Chronic Liver Failure 03/2023 - 06/2020
2	Hepatocellular Carcinoma (Hepatoma) 03/2023 - 05/2008
2	Infarction (Infarctions) 01/2023 - 11/2020
2	Ischemic Stroke 01/2023 - 06/2019
2	Bites and Stings (Sting) 01/2023 - 01/2023
2	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 06/2022
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2021 - 01/2021
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2020 - 03/2016
2	Thrombosis (Thrombus) 06/2020 - 01/2010
2	Aortic Dissection 01/2020 - 11/2018
2	Ischemia 04/2014 - 08/2013
2	Lymphoid Leukemia 08/2008 - 09/2007
1	Hypoxia (Hypoxemia) 04/2024
1	Colonic Neoplasms (Colon Cancer) 03/2024
1	Retinoblastoma (Glioblastoma, Retinal) 03/2024
1	Sepsis (Septicemia) 09/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2023
1	Obesity 03/2023

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 03/2024 - 08/2005
7	ResveratrolIBA 01/2010 - 09/2005
5	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2008
4	CytokinesIBA 03/2024 - 09/2005
4	MicroRNAs (MicroRNA)IBA 05/2023 - 01/2021
4	Immune Checkpoint InhibitorsIBA 03/2023 - 06/2022
4	Toll-Like Receptor 4IBA 01/2021 - 11/2018
4	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2019 - 07/2014
3	VaccinesIBA 12/2023 - 07/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2022 - 08/2021
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2021 - 10/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 09/2007
3	pseudolaric acid BIBA 06/2018 - 04/2012
3	Interleukin-17 (Interleukin 17)IBA 12/2017 - 02/2016
2	LigandsIBA 04/2024 - 03/2023
2	Oxygen (Dioxygen)IBA 04/2024 - 01/2017
2	GoldIBA 01/2024 - 01/2023
2	AlbuminsIBA 09/2023 - 01/2023
2	C-Reactive ProteinIBA 09/2023 - 06/2022
2	AntigensIBA 03/2023 - 03/2009
2	Mannose (D-Mannose)IBA 03/2023 - 01/2023
2	B7-H1 AntigenIBA 01/2023 - 01/2022
2	oxidized low density lipoproteinIBA 01/2023 - 06/2018
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2020
2	Fibrinogen (Factor I)FDA Link 12/2022 - 01/2022
2	polydopamineIBA 06/2022 - 01/2022
2	Circular RNAIBA 12/2021 - 01/2021
2	Apolipoproteins E (ApoE)IBA 05/2020 - 05/2019
2	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2019 - 08/2013
2	DinitrofluorobenzeneIBA 01/2013 - 04/2012
1	AGRO 100IBA 04/2024
1	N-methyladenosineIBA 04/2024
1	SteroidsIBA 04/2024
1	EcdysoneIBA 04/2024
1	Epidermal Growth Factor (EGF)IBA 04/2024
1	RNA Polymerase II (RNA Polymerase B)IBA 03/2024
1	Chitinase-3-Like Protein 1IBA 02/2024
1	MXeneIBA 01/2024
1	COVID-19 VaccinesIBA 12/2023
1	Cyclin B1IBA 12/2023
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 12/2023
1	Cyclin-Dependent Kinase 2IBA 12/2023
1	dachengqi decoctionIBA 09/2023
1	ProcalcitoninIBA 09/2023
1	6-methyladenineIBA 03/2023
1	InterferonsIBA 01/2023
1	SodiumIBA 01/2023
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2023
1	AntibodiesIBA 01/2023

Therapy/Procedure

17	Therapeutics 03/2024 - 08/2005
7	Immunotherapy 04/2024 - 01/2022
3	Photothermal Therapy 04/2024 - 06/2022
3	Drug Therapy (Chemotherapy) 07/2022 - 01/2019
3	Stents 01/2010 - 07/2003
2	Liver Transplantation 03/2023 - 06/2020
2	Transplantation 01/2023 - 04/2018
2	Immunomodulation 05/2008 - 09/2007
1	Resuscitation 09/2023